EPA:DHA 6:1 is a superior omega-3 PUFAs formulation attenuating platelets-induced contractile responses in porcine coronary and human internal mammary artery by targeting the serotonin pathway via an increased endothelial formation of nitric oxide

Faraj Zgheel, Stéphanie Perrier, Lamia Remila, Ursula Hounguè, Jean‐Philippe Mazzucotelli, Olivier Morel, Cyril Auger, Valérie B. Schini-Kerth

European Journal of Pharmacology · 2019 · 17 citations · 24 references

DOIFull text

Open access

Concepts

References

24